Validating drug production processes need not be a headache, according to AI researchers who say machine learning (ML) could be a single answer to biopharma’s multivariate problem. The FDA defines ...

AI refers to a machine-based system and ML refers to a set of techniques that can be used to train AI algorithms (2) so ML should not be considered outside the scope of AI.